axg11

43 ms·

451.
by axg11 5y ago
I know it's aimed at businesses, but this would also be a great UX to pay friends or others when selling on Craigslist/Kijiji
452.
by axg11 5y ago
Gov.uk is _the_ primary way that anyone interacts with the UK government. Why shouldn't it be one of the highest priority aspects of government? I don't think the Prime Minister was sitting in on daily standups and sprint planning
453.
by axg11 5y ago
Derek Lowe is rightfully pointing out that protein structures (AlphaFold's main purpose) is not the rate limiting step in drug discovery today. Other articles overhype AlphaFold's achievements and this one pours water on that, a n
454.
by axg11 5y ago
The relentless number of anti-crypto and anti-web3 articles on HN is tiring. Nobody is forcing anyone to partake in this new technology. Skepticism is healthy, but criticism without being constructive is not. There are clearly _some_ novel
455.
by axg11 5y ago
A very very profitable, high margin obstacle to the experience.
456.
by axg11 5y ago
How can you honestly say the "let a thousand flowers bloom" approach failed? Google scraps a lot of products, but they still have many great products: Gmail/GSuite, Android, YouTube, GCP, Nest... Each of those is a successful
457.
by axg11 5y ago
How would the world react if there was a Chinese company that was launching an equivalent number of satellites as Starlink? I except the discussions would be very different, and there would be many more calls to stop SpaceX/Starlink.
458.
by axg11 5y ago
I work on ML recommendation algos for a big Facebook-sized company, so perhaps I can give some insight on how this model could be used. This is an example and might not resemble anything they're doing internally. This is more ELI16: Fa
459.
by axg11 5y ago
Are there any sources or predictions on how Paxlovid production and availability will scale? I'm specifically wondering when (if ever) Paxlovid will be widely available and begin to have an impact on COVID hospitalization.
460.
by axg11 5y ago
Everything in society that can be criticized, will be criticized by a subgroup. Even still, I don't think Big Pharma gets enough credit for the multiple vaccines and treatments developed over the last two years.
461.
by axg11 5y ago
This is an interesting thesis. How would HR/People/Recruitment teams work effectively in a world where there are many specialized and actively used job boards? Today, HR teams usually post jobs on LinkedIn and perhaps one or two m
462.
by axg11 5y ago
Would love a link/source for this if you have one.
463.
Retrieval Transformers for Health and Medicine(arsham.substack.com)
1 points by axg11 5y ago|0 comments
464.
by axg11 5y ago
I agree with you. I can understand why a theoretical physicist would find this format frustrating to read. For a layman, the forced tempo of threads helps me understand each point before I move on.
465.
by axg11 5y ago
My point (a view shared by the article and many others) is that the FDA decided Aduhelm is safe but did a terrible job of deciding that it is effective. Safety is also not absolute. All medicines have adverse effects, safety is then relativ
466.
by axg11 5y ago
Free-market folks could argue: what's the point of the FDA here? The organizations that bear the cost of the medicine have decided that there isn't enough evidence of benefit from Aduhelm and further clinical evidence is required.
467.
Ask HN: HN-like community for biology and medicine?
8 points by axg11 5y ago|1 comments
468.
by axg11 5y ago
Couldn’t you say the same thing about the deed for a house?
469.
by axg11 5y ago
The study really doesn't suggest that. All it suggests is that EBV seropositive people are much more likely to develop MS than the seronegative minor population. As for long COVID, the data quality is very variable. I'd like to se
470.
by axg11 5y ago
Great question. A related question: how many undiscovered viruses exist that are beneficial to the host?
471.
by axg11 5y ago
That's an example of a bad use of chatbots, but I don't think that means all chatbots are a bad interface. Chat is good when you have a large potential problem space and a wide range in the tech abilities of your users. A 90 year
472.
by axg11 5y ago
Yes, I'm basing this on experience. A non-savvy user sees most modern UIs as overwhelming, difficult to navigate and they don't have the same priors that the average HN reader does. When they see a chat pop-up, they see a familiar
473.
by axg11 5y ago
This is a great finding. If I were on one of the teams developing an EBV vaccine (e.g. Moderna) I would be a little worried about the possible knock-on effects of the vaccine as a result of this study. MS is an auto-immune disorder, so it&#
474.
by axg11 5y ago
Is it not unfair to expect GPT-3 to perfectly tackle this issue when it has been trained as a general purpose model? For customer support or other more specific chatbot applications there are better machine learning models.
475.
by axg11 5y ago
I see this opinion come up on HN frequently. You are not the intended target for a chatbot. You're right; for most tech-savvy users, the ideal interaction would be through a well designed UI. However, there's a significant portion
476.
by axg11 5y ago
Does this technology only work in select places or are underground caverns fairly commonplace?
477.
by axg11 5y ago
Thanks for adding this information. I was unfair to judge so harshly and be so sceptical. So the $1T question is ... what (if anything) is this model currently predicting about the next variant?
478.
by axg11 5y ago
This isn't true for the field of biology or medicine. If you take a look at the order of authors on the paper in question you can also see that the ordering is not alphabetical.
479.
by axg11 5y ago
Impressive if true, although I am very sceptical of the results. The real test is to put their neck on the line and predict/warn of the next significant variant. If the authors are not willing to do this, I doubt that the algorithm is
480.
by axg11 5y ago
There’s a fixation on this “pointer” problem with NFTs. Most projects use IPFS, making this a non-issue. There are plenty of other critiques of NFTs - this is not one of them.

More ›